Furthermore, in an animal model of treatment-refractory depression with chronic administration of adrenocorticotropic hormone (ACTH), animals that responded to ketamine exhibited higher baseline plasma concentrations of C-reactive protein (CRP) and tumoral necrosis factor-α (TNF-α) (32, 33). This evidence concerns the gene CRP and depressive symptom measurement.